Prospective randomized study of peginterferon alpha-2a, ribavirin and amantadine vs peginterferon alpha-2a plus ribavirin, in hepatitis C patients now responders or relapsers to interferon-alpha and ribavirin
| Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
|---|---|
| Data(s) |
20/05/2014
20/05/2014
01/01/2006
|
| Formato |
S209-S209 |
| Identificador |
http://dx.doi.org/10.1016/S0168-8278(06)80562-3 Journal of Hepatology. Amsterdam: Elsevier B.V., v. 44, p. S209-S209, 2006. 0168-8278 http://hdl.handle.net/11449/34019 10.1016/S0168-8278(06)80562-3 WOS:000237328100562 |
| Idioma(s) |
eng |
| Publicador |
Elsevier B.V. |
| Relação |
Journal of Hepatology |
| Direitos |
closedAccess |
| Tipo |
info:eu-repo/semantics/conferenceObject |
